Payment overview · 2025
General Payments
$42.91
2 reported records · 2 companies
Healthcare provider profile · identity verified
Hema Azad, MD
Allopathic & Osteopathic Physicians|Internal Medicine · MELROSE PARK, IL · NPI 1669523825
Verified facts
What the public records show
CMS Open Payments records show Hema Azad, MD received $42.91 in general payments during 2025 across 2 reported records.
Lundbeck LLC accounted for 59.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Lundbeck LLC | Unresolved — no canonical attribution shown | $25.72 | 59.9% | 1 | 2025 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $17.19 | 40.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $42.91 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Lundbeck LLC | $25.72 | 1 | 2025 |
Source payment records
|
|||||
| JARDIANCE Normalized: jardiance |
Drug | Boehringer Ingelheim Pharmaceuticals, Inc. | $17.19 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 542 | 137 |
| Amlodipine Besylate | Amlodipine Besylate | 451 | 104 |
| Eliquis | Apixaban | 279 | 35 |
| Levothyroxine Sodium | Levothyroxine Sodium | 256 | 53 |
| Pantoprazole Sodium | Pantoprazole Sodium | 248 | 69 |
| Gabapentin | Gabapentin | 241 | 57 |
| Lisinopril | Lisinopril | 214 | 51 |
| Allopurinol | Allopurinol | 193 | 29 |
| Carvedilol | Carvedilol | 187 | 48 |
| Metformin Hcl | Metformin Hcl | 186 | 45 |
| Metoprolol Tartrate | Metoprolol Tartrate | 163 | 39 |
| Furosemide | Furosemide | 153 | 44 |
| Tamsulosin Hcl | Tamsulosin Hcl | 147 | 40 |
| Enoxaparin Sodium | Enoxaparin Sodium | 144 | 14 |
| Metoprolol Succinate | Metoprolol Succinate | 130 | 38 |
| Losartan Potassium | Losartan Potassium | 128 | 34 |
| Hydrochlorothiazide | Hydrochlorothiazide | 120 | 33 |
| Gemtesa | Vibegron | 115 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 110 | 20 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 103 | 42 |
| Levetiracetam | Levetiracetam | 93 | 15 |
| Trazodone Hcl | Trazodone Hcl | 90 | 17 |
| Enalapril Maleate | Enalapril Maleate | 87 | 13 |
| Potassium Chloride | Potassium Chloride | 85 | 34 |
| Famotidine | Famotidine | 82 | 20 |
| Hydralazine Hcl | Hydralazine Hcl | 79 | 24 |
| Omeprazole | Omeprazole | 74 | 19 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 69 | 19 |
| Simvastatin | Simvastatin | 68 | 18 |
| Alprazolam | Alprazolam | 65 | 15 |
| Glipizide | Glipizide | 64 | 16 |
| Heparin Sodium | Heparin Sodium,porcine | 60 | suppressed |
| Mirtazapine | Mirtazapine | 60 | 12 |
| Sertraline Hcl | Sertraline Hcl | 58 | 11 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 54 | 19 |
| Glipizide Er | Glipizide | 53 | 13 |
| Montelukast Sodium | Montelukast Sodium | 53 | 19 |
| Escitalopram Oxalate | Escitalopram Oxalate | 52 | 12 |
| Xarelto | Rivaroxaban | 50 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 50 | suppressed |
| Risperidone | Risperidone | 47 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 46 | 11 |
| Donepezil Hcl | Donepezil Hcl | 46 | suppressed |
| Ibuprofen | Ibuprofen | 46 | suppressed |
| Memantine Hcl | Memantine Hcl | 46 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 44 | 14 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 42 | suppressed |
| Valsartan | Valsartan | 42 | suppressed |
| Finasteride | Finasteride | 41 | suppressed |
| Nifedipine Er | Nifedipine | 40 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 39 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 39 | 18 |
| Pregabalin | Pregabalin | 38 | suppressed |
| Spironolactone | Spironolactone | 38 | 11 |
| Azithromycin | Azithromycin | 37 | 31 |
| Divalproex Sodium | Divalproex Sodium | 36 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 35 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 33 | 25 |
| Colchicine | Colchicine | 30 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 30 | suppressed |
| Baclofen | Baclofen | 29 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 28 | suppressed |
| Insulin Lispro | Insulin Lispro | 28 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 27 | 11 |
| Meloxicam | Meloxicam | 26 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 25 | suppressed |
| Cephalexin | Cephalexin | 25 | 19 |
| Niacin Er | Niacin | 25 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 24 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 24 | 11 |
| Prednisone | Prednisone | 24 | 11 |
| Haloperidol Decanoate | Haloperidol Decanoate | 22 | suppressed |
| Latanoprost | Latanoprost | 22 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 22 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 22 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 22 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 21 | 18 |
| Oxcarbazepine | Oxcarbazepine | 21 | suppressed |
| Phenytoin | Phenytoin | 21 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 20 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 19 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 19 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 19 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 18 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 18 | suppressed |
| Lactulose | Lactulose | 18 | suppressed |
| Januvia | Sitagliptin Phosphate | 17 | suppressed |
| Lorazepam | Lorazepam | 17 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 17 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 17 | suppressed |
| Temazepam | Temazepam | 17 | suppressed |
| Celecoxib | Celecoxib | 16 | suppressed |
| Chlorthalidone | Chlorthalidone | 16 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 16 | suppressed |
| Ezetimibe | Ezetimibe | 16 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 16 | suppressed |
| Primidone | Primidone | 16 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 15 | 11 |
| Fiasp | Insulin Aspart (Niacinamide) | 15 | suppressed |
| Folic Acid | Folic Acid | 15 | suppressed |
| Glimepiride | Glimepiride | 15 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 15 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 15 | suppressed |
| Bumetanide | Bumetanide | 14 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 14 | suppressed |
| Glucagon Emergency Kit | Glucagon | 14 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 14 | suppressed |
| Meropenem | Meropenem | 14 | suppressed |
| Methocarbamol | Methocarbamol | 14 | suppressed |
| Methylprednisolone | Methylprednisolone | 14 | 11 |
| Midodrine Hcl | Midodrine Hcl | 14 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 14 | suppressed |
| Novolog | Insulin Aspart | 14 | suppressed |
| Nystatin | Nystatin | 14 | 11 |
| Sevelamer Carbonate | Sevelamer Carbonate | 14 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 14 | 12 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Cilostazol | Cilostazol | 13 | suppressed |
| Diazepam | Diazepam | 13 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 13 | 11 |
| Incruse Ellipta | Umeclidinium Bromide | 13 | suppressed |
| Insulin Aspart | Insulin Aspart | 13 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 13 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 13 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 12 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 12 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 12 | suppressed |
| Haloperidol | Haloperidol | 12 | suppressed |
| Hydrocortisone | Hydrocortisone | 12 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 12 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 12 | suppressed |
| Sodium Polystyrene Sulfonate | Sodium Polystyrene Sulfonate | 12 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 12 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 11 | suppressed |
| Anastrozole | Anastrozole | 11 | suppressed |
| Armour Thyroid | Thyroid,pork | 11 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 11 | suppressed |
| Clonazepam | Clonazepam | 11 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 11 | suppressed |
| Digoxin | Digoxin | 11 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 11 | suppressed |
| Klor-Con M20 | Potassium Chloride | 11 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 11 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 11 | suppressed |
| Synthroid | Levothyroxine Sodium | 11 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $42.91 · 2 records | Lundbeck LLC | JARDIANCE, REXULTI | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error